People with type 2 diabetes often face serious health challenges, especially if they also have kidney disease. These individuals are at high risk of kidney failure, heart attacks, strokes, and even death. For years, the main treatment to protect their kidneys has been a therapy called renin-angiotensin-aldosterone system (RAAS) blockade.
While this therapy has been helpful, it has its limits. Now, researchers at Stanford University have found a new way to help these patients, using a drug called canagliflozin.
The study, which involved 4,401 participants from 34 different countries, aimed to see if canagliflozin could do a better job of protecting kidneys than the current standard therapy. All participants were already receiving the best available care for kidney disease, which included RAAS therapy.
They were then randomly divided into two groups: half received canagliflozin, and the other half received a placebo—a harmless pill with no medical effect.
The results were very promising. The researchers found that people who took canagliflozin had a 30% lower risk of developing kidney failure or dying from kidney or heart-related problems compared to those who took the placebo.
Even more specifically, the risk of kidney failure alone was cut by 34% in the canagliflozin group. These results suggest that the drug is not just helping with symptoms; it is actually protecting the kidneys from further damage.
The benefits didn’t stop there. The study also showed that people taking canagliflozin had a 31% lower chance of being hospitalized for heart failure or dying from heart-related issues. For people with type 2 diabetes, heart disease is a major concern, so this added benefit is especially important.
Canagliflozin works in a unique way. It belongs to a class of drugs called SGLT2 inhibitors. Normally, when blood passes through the kidneys, a lot of sugar is reabsorbed back into the bloodstream.
Canagliflozin blocks this process, causing the kidneys to remove more sugar from the body through urine. This helps lower blood sugar levels, which is important for managing diabetes. But this study shows that it also has a protective effect on the kidneys and the heart.
In fact, canagliflozin is not new to the medical world. It has already been approved by the U.S. Food and Drug Administration (FDA) for lowering blood sugar levels in people with type 2 diabetes.
It is also approved for reducing the risk of heart problems in people with both type 2 diabetes and existing heart disease. This new research adds to its list of benefits by showing it can also protect against kidney failure.
This discovery is a big step forward for people with type 2 diabetes and kidney disease. Until now, RAAS blockade therapy was the only approved method to slow down kidney damage.
Now, with the addition of canagliflozin, there is hope for even better protection. It means that patients who are at risk of kidney failure now have another tool to help manage their condition and reduce their chances of serious health problems.
The researchers are excited about what this could mean for the future. They hope that more doctors will consider prescribing canagliflozin to patients with type 2 diabetes and kidney disease. It could help many people avoid the pain and suffering of kidney failure and heart problems, improving their quality of life and extending their lifespan.
In summary, this study shows that canagliflozin is more than just a diabetes drug—it is also a powerful protector of kidney health. For people living with type 2 diabetes, adding this drug to their treatment plan could make a significant difference in preventing serious complications.
As more research continues, canagliflozin may become a regular part of managing both diabetes and kidney disease, offering hope and better health to millions of people around the world.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and drinking coffee could help reduce risk of kidney injury.
For more information about kidney health, please see recent studies about foods that may prevent recurrence of kidney stones, and eating nuts linked to lower risk of chronic kidney disease and death.
Copyright © 2025 Knowridge Science Report. All rights reserved.
